The is still conducting analyzes on the price purchase price of the institution has not yet been defined but should retreat from the indications given by the Brazilian group previously, said the president of BRB on Thursday (10).
“The diligence at this time is concentrated in the credit portfolio (…) yes, it is likely that the perimeter of the transaction that will exclude much more than the $ 23 billion we disclosed in conversations with the press,” said Paulo Henrique Bezerra Rodrigues Costa, in a conference after the release of BRB’s quarter -quarter results.
“Only credit operations that are aligned with the objectives of the new conglomerate will be considered as a perimeter for the business to be analyzed by the Central Bank,” he added.
Last week, Costa said in an interview with Reuters That the agreement announced by the bank controlled by the Federal District Government will involve the purchase of Master’s healthier and most strategically relevant assets for BRB and which occurred after which Costa called months of negotiations.
At the time, Costa stated that the diligence process could eventually reduce the negotiated price of $ 2 billion, to be paid up to six years.
On Thursday, Costa said the Master’s operations that are interested in BRB are those dealing with medium and large companies, payroll loans and exchange services.
Continues after advertising
“Therefore, assets that do not have guarantees or risk profile aligned with those of BRB will not be part,” added the president of the bank.
Asked if the master’s slices in companies such as OncoClincas could be part of the transaction with BRB, Costa stated that “no participation in any company that is not in banking is part of this transaction.”
